Neuronetics, Inc. (STIM) Social Stream



Neuronetics, Inc. (STIM): $4.27

-0.39 (-8.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Neuronetics Inc (STIM) Price Targets From Analysts

Use the tables below to see what analysts covering Neuronetics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-14 4 $12 $12 $12 $3.06 292.16%
2021-11-09 4 $12 $10 $11 $3.06 259.48%
2022-01-17 4 $12 $9 $10.5 $3.06 243.14%
2022-03-08 4 $12 $8 $10 $3.06 226.8%

The Trend in the Analyst Price Target


Over the past 50 weeks, STIM's average price target has gone down $12.5.

STIM reports an average of 122.05% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-11 3 23 21 21.5 15.63 37.56%
2021-08-24 3 21 12 17.5 7.67 128.16%
2021-10-14 4 12 12 12.0 4.94 142.91%
2021-11-09 4 12 10 11.0 5.53 98.92%
2022-03-08 4 12 8 10.0 2.87 248.43%

STIM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


Over the past 16 months, STIM's average broker recommendation rating worsened by 0.6.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Neuronetics Inc's upside potential (average analyst target price relative to current price) is greater than 363.67% of them.
  • In terms of how Neuronetics Inc fares relative to all US stocks, note that its average analyst price target is greater than 39.36% of that group.
  • In terms of how Neuronetics Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than 16.41% of that group.
  • Neuronetics Inc's number of analysts covering the stock is greater than 93.08% of Healthcare stocks.

In the Medical Equipment industry, SRDX, SPNE, and SIBN are the three stocks most similar to Neuronetics Inc regarding the price target and analyst recommendation information presented here.

Is STIM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4896 seconds.